Survivorship after Hematopoietic Cell Transplantation

In this engaging video, Alison Loren, MD, reports on survivorship among patients following autologous and allogeneic hematopoietic cell transplantation. Defining the well-known risk factors, prognostic indicators and long­term complications for HCT, Dr. Loren offers an overview of the future for these populations, who are generally at greater risk for mortality and morbidity as a result of second cancers (oral, esophageal, breast and lung) and organ failure as well as relapse and chronic host vs. graft disease.

Related Links

• Clinical Brief: Enrolling Clinical Trials: Umbilical Cord Blood Transplantation vs Haploidentical Transplantation for Patients with Hematological Malignancies
• Dr. Loren’s Profile